Patents by Inventor Graham Rook

Graham Rook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunotherapeutic agent
    Patent number: 7569213
    Abstract: The invention relates to a compound which is an ester of 1,2,3-propanetriol with one or more C11 to C24 fatty acids, wherein at least one fatty acid has at least one double bond. The compound is useful in the treatment of chronic inflammatory disorders.
    Type: Grant
    Filed: November 22, 2005
    Date of Patent: August 4, 2009
    Assignee: Stanford Rook Limited
    Inventors: Laura Rosa Brunet, Graham Rook
  • Immunotherapeutic Agent
    Publication number: 20080004341
    Abstract: The invention relates to a compound which is an ester of 1,2,3-propanetriol with one or more C11 to C24 fatty acids, wherein at least one fatty acid has at least one double bond. The compound is useful in the treatment of chronic inflammatory disorders.
    Type: Application
    Filed: November 22, 2005
    Publication date: January 3, 2008
    Inventors: Laura Rosa Brunet, Graham Rook
  • Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
    Patent number: 6878377
    Abstract: Antigenic and/or immunogenic material derived from Mycobacterium vaccae is used to down-regulate Th2 activity of the immune system without up-regulation of Th1 activity. Disorders such as Chronic Fatigue Syndrome, Gulf War Syndrome and Total Allergy Syndrome are treated. The material preferably comprises dead M. vaccae cells in a composition which does not include a non-M. vaccae antigen, immunogen or allergen.
    Type: Grant
    Filed: January 18, 2001
    Date of Patent: April 12, 2005
    Assignee: Stanford Rook Limited
    Inventors: Graham A. Rook, John L. Stanford, Alimuddin L. Zumla
  • Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
    Publication number: 20010018057
    Abstract: Antigenic and/or immunogenic material derived from Mycobacterium vaccae is used to down-regulate Th2 activity of the immune system without up-regulation of Th1 activity. Disorders such as Chronic Fatigue Syndrome, Gulf War Syndrome and Total Allergy Syndrome are treated. The material preferably comprises dead M. vaccae cells in a composition which does not include a non-M. vaccae antigen, immunogen or allergen.
    Type: Application
    Filed: January 18, 2001
    Publication date: August 30, 2001
    Applicant: STANFORD ROOK LIMITED
    Inventors: Graham A. Rook, John L. Stanford, Alimuddin L. Zumla